SCOPA 2022: A review of topical medication classes in eyecare

Video

Brad Sutton, OD, FAAO, FORS, shares highlights from his SCOPA 2022 presentation, "Topical Pharmacology Rounds."

Brad Sutton, OD, FAAO, FORS, clinical professor at Indiana University School of Optometry, and service chief of the Indianapolis Eye Care Center speaks with Optometry Times® editor Kassi Jackson, sharing highlights from his presentation, "Topical pharmacology rounds," which he presented during this year's South Carolina Optometric Physicians Association's (SCOPA) annual meeting in hilton Head.

This transcript has been lightly edited for clarity:

Brad Sutton, OD, FAAO, FORS:

This is a talk I've given ... throughout the country, and it seems to be a pretty well-received review of basically all topical medication classes that we use in optometry—or eyecare.— in general.

I kind of cover each drug that we have out there, kind of hit on some newer drugs that are just coming to the market, some things in the pipeline a little bit.

And the goal is to give a little bit of background on how the drugs work, and how one drug may be similar or different from another, but my real goal during the talk is always to say, "Okay, here are some clinical nuances between drug X and drug Y," and help attendees better use those medications in their practice to take care of their patients.

We cover antibiotics, anti-inflammatories, nonsteroidal anti-inflammatories, allergy medicines, glaucoma drops, antivirals, and basically every category you can think of.

Recent Videos
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
For Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, last week's conference gives a unique opportunity for optometrists and ophthalmologists to collaborate.
Ashley Mills, The Vision Council CEO, outlines new additions to the show that are unveiling what is to come in terms of fashion, technology, and patient care.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.
© 2025 MJH Life Sciences

All rights reserved.